Literature DB >> 7537121

Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors.

J C van der Loo1, R E Ploemacher.   

Abstract

The cobblestone-area forming cell (CAFC) assay permits a direct measurement of the seeding of primitive and more mature murine hematopoietic stem cell subsets by comparing the number of CAFC in the original transplant with the number of CAFC retrieved from bone marrow (BM) and spleen after transplantation. We found no differences in seeding efficiency between the more mature and primitive CAFC subsets, nor between seeding efficiencies of stem cells from low-density (LD) fractions of normal and day-6 post-5-fluorouracil BM. The data show that 18% to 20% of all intravenously transplanted stem cell subsets seed to the BM, whereas 8% to 10% seed to the spleen. In addition, similar seeding efficiencies were found for day-12 spleen colony-forming unit (CFU-S-12) as was determined by retransplantation. Previously, it has been reported that a 2- to 3-hour preincubation of BM with interleukin-3 (IL-3) enhances the in vivo repopulating ability of a graft. To test whether hematopoietic growth factors affected this increased engraftment by enhancing the seeding of the transplanted marrow, we assessed the 16- to 18-hour seeding efficiency of short- and long-term in vivo repopulating stem cell subsets to BM and spleen using the CAFC assay, after preincubation with or without hematopoietic growth factors. A 2- to 3-hour preincubation with IL-3, or a combination of IL-3, IL-12, and steel factor, at 37 degrees C, led to a substantial decrease in seeding compared with control (which was kept on ice) of all hematopoietic subsets measured, both in spleen and BM. In concert with these data, the long-term in vivo repopulating ability of growth-factor incubated BM was also decreased when compared with control. In conclusion, we have been unable to observe a beneficial effect of growth factor preincubation on the repopulating ability of a graft.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537121

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

Review 1.  The therapeutic potential of embryonic and adult stem cells for skeletal muscle regeneration.

Authors:  Radbod Darabi; Filipe N C Santos; Rita C R Perlingeiro
Journal:  Stem Cell Rev       Date:  2008-07-08       Impact factor: 5.739

2.  Hematopoietic stem cells do not engraft with absolute efficiencies.

Authors:  Fernando D Camargo; Stuart M Chambers; Erin Drew; Kelly M McNagny; Margaret A Goodell
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

3.  Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors.

Authors:  Radbod Darabi; Filipe N C Santos; Antonio Filareto; Weihong Pan; Ryan Koene; Michael A Rudnicki; Michael Kyba; Rita C R Perlingeiro
Journal:  Stem Cells       Date:  2011-05       Impact factor: 6.277

4.  Intrabone transplantation of CD34+ cells with optimized delivery does not enhance engraftment in a rhesus macaque model.

Authors:  Kate Stringaris; Robert F Hoyt; Jan K Davidson-Moncada; Jeremy M Pantin; John F Tisdale; Naoya Uchida; Lydia N Raines; Robert Reger; Noriko Sato; Cynthia E Dunbar; Timothy J Hunt; Randall R Clevenger; Allen Krouse; Mark E Metzger; Aylin C Bonifacino; William Telford; Peter L Choyke; Theresa Engels; Robert E Donahue; Richard W Childs
Journal:  Blood Adv       Date:  2020-12-22

5.  Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1.

Authors:  D Y Jo; S Rafii; T Hamada; M A Moore
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

6.  Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin.

Authors:  M Yagi; K A Ritchie; E Sitnicka; C Storey; G J Roth; S Bartelmez
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 7.  Status of umbilical cord blood transplantation in the year 2001.

Authors:  J M Hows
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

Review 8.  Engineering the hematopoietic stem cell niche: Frontiers in biomaterial science.

Authors:  Ji Sun Choi; Bhushan P Mahadik; Brendan A C Harley
Journal:  Biotechnol J       Date:  2015-09-10       Impact factor: 4.677

9.  Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells.

Authors:  J Audet; C L Miller; S Rose-John; J M Piret; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

10.  Current progress and challenges in HIV gene therapy.

Authors:  Janet Chung; John J Rossi; Ulrike Jung
Journal:  Future Virol       Date:  2011-11-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.